Viad Corp (VVI)
(Delayed Data from NYSE)
$34.69 USD
+1.87 (5.70%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $34.70 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.69 USD
+1.87 (5.70%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $34.70 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum B VGM
Zacks News
Should Value Investors Buy Mitie Group (MITFY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What Makes Viad (VVI) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Viad (VVI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Viad (VVI) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Viad (VVI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Are Investors Undervaluing APi Group (APG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
APi Group Corporation (APG) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
APi (APG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights Barrett Business Services, Shift4 Payments, Carrols Restaurant Group, Brown & Brown, and Limbach
by Zacks Equity Research
Barrett Business Services, Shift4 Payments, Carrols Restaurant Group, Brown & Brown, and Limbach are part of the Zacks top Analyst Blog.
Invest in These 5 Small Hidden Gems for Solid Returns in 2024
by Nalak Das
We have narrowed our search to five Small-Cap Stocks. These are: LMB, BBSI, TAST, CAPL, VVI.
Best Momentum Stock to Buy for December 7th
by Zacks Equity Research
AQST and VVI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 7, 2023.
Are Investors Undervaluing Concentrix (CNXC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
How Much Upside is Left in Viad (VVI)? Wall Street Analysts Think 27.29%
by Zacks Equity Research
The consensus price target hints at a 27.3% upside potential for Viad (VVI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Should Value Investors Buy APi Group (APG) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Fast-paced Momentum Stock Viad (VVI) Is Still Trading at a Bargain
by Zacks Equity Research
Viad (VVI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
New Strong Buy Stocks for November 27th
by Zacks Equity Research
VVI, AVTX, RYI, TM and HIBB have been added to the Zacks Rank #1 (Strong Buy) List on November 27, 2023.
New Strong Buy Stocks for November 21st
by Zacks Equity Research
AQST, RBT, HARP, VVI and AVTX have been added to the Zacks Rank #1 (Strong Buy) List on November 21, 2023.
Viad (VVI) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Viad (VVI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Can Viad (VVI) Climb 36.16% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Viad (VVI) points to a 36.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Why Fast-paced Mover Viad (VVI) Is a Great Choice for Value Investors
by Zacks Equity Research
Viad (VVI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Zacks.com featured highlights include Amicus Therapeutics, Genius Sports and Viad
by Zacks Equity Research
Amicus Therapeutics, Genius Sports and Viad are part of the Zacks Screen of the Week article.
3 Stocks Worth a Watch for Solid Earnings Acceleration
by Tirthankar Chakraborty
Some of the notable companies to have witnessed solid earnings acceleration as of now are Amicus Therapeutics (FOLD), Genius Sports (GENI) and Viad (VVI).
Viad (VVI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of 12.50% and 5.97%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing Mitie Group (MITFY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Viad (VVI) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of 17.86% and 11.78%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Crawford & Company B (CRD.B) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Crawford & Company B (CRD.B) delivered earnings and revenue surprises of 64.71% and 4.84%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
SPS Commerce (SPSC) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
SPS Commerce (SPSC) delivered earnings and revenue surprises of 17.54% and 1.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Viad (VVI) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of -9.92% and 10.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?